pentoxifylline has been researched along with Familial Spastic Paraparesis, Htlv-1-Associated in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, M | 1 |
| Nakahara, K | 1 |
| Maruyama, Y | 1 |
| Kawabata, M | 1 |
| Higuchi, I | 1 |
| Kubota, H | 1 |
| Izumo, S | 1 |
| Arimura, K | 1 |
| Osame, M | 1 |
| Tsujino, A | 2 |
| Nakamura, T | 3 |
| Nishiura, Y | 2 |
| Shirabe, S | 3 |
| Furuya, T | 3 |
| Goto, H | 2 |
| Kawakami, A | 1 |
| Eguchi, K | 2 |
| Nagataki, S | 2 |
| Hatae, T | 1 |
| Hara, H | 1 |
| Kobayashi, T | 1 |
| Watanabe, T | 1 |
| Suenaga, A | 1 |
| Nakane, S | 2 |
| Yoshimura, T | 2 |
| Fujimoto, T | 1 |
| Kambara, C | 1 |
| Hamasaki, S | 1 |
2 trials available for pentoxifylline and Familial Spastic Paraparesis, Htlv-1-Associated
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory A | 1996 |
Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Prosp | 1997 |
3 other studies available for pentoxifylline and Familial Spastic Paraparesis, Htlv-1-Associated